Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.
We accept advertising relevant to the interests of our members.
For more information, see:
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
| Also see Pharma Marketing News OpEd Pieces |
Less DTC, Better Public Image?
Posted: December 7, 2005A lot of attention is being paid these days to pharma's tarnished public image. The discussion regarding J&J's reputation by several members of the online PHARMA-MKTING discussion group shed further light on the relationship between DTC and pharma's image crisis.In today's post to Pharma Marketing Blog, I summarize yesterday's online discussion and focus on other reasons for J&J's good reputation aside from its handling of the 1980's Tylenol tampering situation. That was so long ago! That was then, as they say. Recently, J&J has neglected to follow its own "gold standard" of crisis management (I give an example).
Today's Pharma Marketing Blog post also pays tribute to another 1980's defining moment much in the news today: the death of John Lennon.
For more on this topic, read today's post to Wall Street Journal's favorite pharmaceutical industry blog.